Telix Pharmaceuticals Limited (ASX: TLX) announced a significant licensing agreement under which the company will receive an upfront payment of $40 million.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
In addition, if certain research and development, regulatory, and commercialization milestones are achieved in the future, Telix will also be eligible to receive up to a total of $2.1 billion. The agreement also includes royalty arrangements based on future product sales. This transaction highlights the value of Telix's leading technology in the field of radiopharmaceuticals and the enormous market potential of its products.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Chaos Labs discloses high concentration of WLFI collateral cycle and Dolomite lending
ForesightNews•2026/04/13 00:54
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$71,229.57
-2.52%
Ethereum
ETH
$2,207.24
-3.39%
Tether USDt
USDT
$1
-0.01%
XRP
XRP
$1.33
-1.61%
BNB
BNB
$595.88
-1.77%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$82.14
-3.23%
TRON
TRX
$0.3221
+0.90%
Dogecoin
DOGE
$0.09137
-1.80%
Hyperliquid
HYPE
$41.03
-4.03%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now